New combo therapy shows promise for Tough-to-Treat biliary cancers
Disease control
Ongoing
This study tests whether adding the experimental drug CTX-009 to standard chemotherapy (paclitaxel) helps adults with advanced bile duct, gallbladder, or ampullary cancers that have worsened after initial treatment. About 168 participants will receive either the combination or pa…
Phase: PHASE2, PHASE3 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 17, 2026 05:34 UTC